Physical Urticarias and Cholinergic Urticaria

Immunology and Allergy Clinics of North America

Volumn 34, Issue 1, 2014, Pages 73-88

  Abajian, Marina ^a   Schoepke, Nicole ^a   Altrichter, Sabine ^a   Zuberbier, H C Torsten ^a   Maurer, Marcus ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cholinergic urticaria; Cold urticaria; Heat urticaria; Physical urticaria; Pressure urticaria; Solar urticaria; Urticaria factitia; Vibratory urticaria angioedema

Indexed keywords

AFAMELANOTIDE; ANTIHISTAMINIC AGENT; BOTULINUM TOXIN; CYCLOSPORIN A; DAPSONE; ETANERCEPT; HISTAMINE; HISTAMINE H1 RECEPTOR AGONIST; IMMUNOGLOBULIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; INTERLEUKIN 1; LEUKOTRIENE; MONTELUKAST; OMALIZUMAB; PROPRANOLOL; PROSTAGLANDIN D2; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SALAZOSULFAPYRIDINE; SCOPOLAMINE BUTYL BROMIDE; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR INHIBITOR;

ANGIONEUROTIC EDEMA; CHOLINERGIC URTICARIA; CLINICAL PROTOCOL; CLINICAL RESEARCH; COLD CONTACT URTICARIA; DELAYED PRESSURE URTICARIA; DERMOGRAPHISM; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE SEVERITY; HEAT CONTACT URTICARIA; HUMAN; MAST CELL; PHYSICAL URTICARIA; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SOLAR URTICARIA; SYMPTOM; TREATMENT RESPONSE; URTICARIA; VIBRATORY ANGIOEDEMA;

CHOLINERGIC URTICARIA; COLD URTICARIA; HEAT URTICARIA; PHYSICAL URTICARIA; PRESSURE URTICARIA; SOLAR URTICARIA; URTICARIA FACTITIA; VIBRATORY URTICARIA/ANGIOEDEMA;

HUMANS; URTICARIA;

EID: 84888005805     PISSN: 08898561     EISSN: 15578607     Source Type: Journal    
DOI: 10.1016/j.iac.2013.09.010     Document Type: Review

References (107)

1. Abajian M., Mlynek A., Maurer M. Physical urticaria. Curr Allergy Asthma Rep 2012, 12(4):281-287.
2. Magerl M., Borzova E., Gimenez-Arnau A., et al. The definition and diagnostic testing of physical and cholinergic urticarias-EAACI/GA2LEN/EDF/UNEV consensus panel recommendations. Allergy 2009, 64(12):1715-1721.
3. Wanderer A.A., Grandel K.E., Wasserman S.I., et al. Clinical characteristics of cold-induced systemic reactions in acquired cold urticaria syndromes: recommendations for prevention of this complication and a proposal for a diagnostic classification of cold urticaria. JAllergy Clin Immunol 1986, 78(3 Pt 1):417-423.
4. Nichols A.W. Exercise-induced anaphylaxis and urticaria. Clin Sports Med 1992, 11(2):303-312.
5. Kontou-Fili K., Borici-Mazi R., Kapp A., et al. Physical urticaria: classification and diagnostic guidelines. An EAACI position paper. Allergy 1997, 52(5):504-513.
6. Dice J.P. Physical urticaria. Immunol Allergy Clin North Am 2004, 24(2):225-246. vi.
7. Zuberbier T., Althaus C., Chantraine-Hess S., et al. Prevalence of cholinergic urticaria in young adults. JAm Acad Dermatol 1994, 31(6):978-981.
8. Torchia D., Francalanci S., Bellandi S., et al. Multiple physical urticarias. Postgrad Med J 2008, 84(987):e1-e2.
9. Arikan-Ayyildiz Z., Isik S., Caglayan-Sozmen S., et al. Cold, cholinergic and aquagenic urticaria in children: presentation of three cases and review of the literature. Turk J Pediatr 2013, 55(1):94-98.
10. Cheon H.W., Han S.J., Yeo S.J., et al. Acase of combined cholinergic and cold urticaria. Korean J Intern Med 2012, 27(4):478-479.
11. Cohen R.W., Rosenstreich D.L. Discrimination between urticaria-prone and other allergic patients by intradermal skin testing with codeine. JAllergy Clin Immunol 1986, 77(6):802-807.
12. Zuberbier T., Asero R., Bindslev-Jensen C., et al. EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009, 64(10):1417-1426.
13. Zuberbier T., Asero R., Bindslev-Jensen C., et al. EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy 2009, 64(10):1427-1443.
14. Magerl M., Schmolke J., Metz M., et al. Prevention of signs and symptoms of dermographic urticaria by single-dose ebastine 20 mg. Clin Exp Dermatol 2009, 34(5):e137-e140.
15. Fleischer M., Grabbe J. Physical urticaria. Hautarzt 2004, 55(4):344-349. [in German].
16. Zuberbier T., Maurer M. Urticaria: current opinions about etiology, diagnosis and therapy. Acta Derm Venereol 2007, 87(3):196-205.
17. Wallengren J., Isaksson A. Urticarial dermographism: clinical features and response to psychosocial stress. Acta Derm Venereol 2007, 87(6):493-498.
18. Lewis T. Vascular reactions of the skin to injury - 1. Reactions to stroking. Urticaria factita. Heart 1924, 11:119-139.
19. Breathnach S.M., Allen R., Ward A.M., et al. Symptomatic dermographism: natural history, clinical features laboratory investigations and response to therapy. Clin Exp Dermatol 1983, 8(5):463-476.
20. Mayou S.C., Kobza Black A., Eady R.A., et al. Cholinergic dermographism. Br J Dermatol 1986, 115(3):371-377.
21. Warin R.P. Clinical observations on delayed pressure urticaria. Br J Dermatol 1989, 121(2):225-228.
22. Schmidt C.C. Schmidt's Jahrbücher der in- und ausländischen gesammten Medizin 1860, Otto Wigand.
23. Horiko T., Aoki T. Dermographism (mechanical urticaria) mediated by IgM. Br J Dermatol 1984, 111(5):545-550.
24. Newcomb R.W., Nelson H. Dermographia mediated by immunoglobulin E. Am J Med 1973, 54(2):174-180.
25. Bettley F.R. Adevice for the measurement of factitious urticaria. JInvest Dermatol 1962, 39:1.
26. Metz M., Altrichter S., Ardelean E., et al. Anti-immunoglobulin E treatment of patients with recalcitrant physical urticaria. Int Arch Allergy Immunol 2011, 154(2):177-180.
27. Krause K., Degener F., Altrichter S., et al. Cold-induced urticaria and angioedema. Classification, diagnosis and therapy. Hautarzt 2010, 61(9):743-749. [in German].
28. Toda S., Takahagi S., Mihara S., et al. Six cases of antihistamine-resistant dermographic urticaria treated with oral ciclosporin. Allergol Int 2011, 60(4):547-550.
29. Borzova E., Rutherford A., Konstantinou G.N., et al. Narrowband ultraviolet B phototherapy is beneficial in antihistamine-resistant symptomatic dermographism: a pilot study. JAm Acad Dermatol 2008, 59(5):752-757.
30. Kobza-Black A. Delayed pressure urticaria. JInvestig Dermatol Symp Proc 2001, 6(2):148-149.
31. Magerl M., Philipp S., Manasterski M., et al. Successful treatment of delayed pressure urticaria with anti-TNF-alpha. JAllergy Clin Immunol 2007, 119(3):752-754.
32. Alangari A.A., Twarog F.J., Shih M.C., et al. Clinical features and anaphylaxis in children with cold urticaria. Pediatrics 2004, 113(4):e313-e317.
33. Neittaanmaki H. Cold urticaria. Clinical findings in 220 patients. JAm Acad Dermatol 1985, 13(4):636-644.
34. Katsarou-Katsari A., Makris M., Lagogianni E., et al. Clinical features and natural history of acquired cold urticaria in a tertiary referral hospital: a 10-year prospective study. JEur Acad Dermatol Venereol 2008, 22(12):1405-1411.
35. Moller A., Henning M., Zuberbier T., et al. Epidemiology and clinical aspects of cold urticaria. Hautarzt 1996, 47(7):510-514. [in German].
36. Siebenhaar F., Weller K., Mlynek A., et al. Acquired cold urticaria: clinical picture and update on diagnosis and treatment. Clin Exp Dermatol 2007, 32(3):241-245.
37. Krause K., Zuberbier T., Maurer M. Modern approaches to the diagnosis and treatment of cold contact urticaria. Curr Allergy Asthma Rep 2010, 10(4):243-249.
38. Nakamura Y., Kambe N., Saito M., et al. Mast cells mediate neutrophil recruitment and vascular leakage through the NLRP3 inflammasome in histamine-independent urticaria. JExp Med 2009, 206(5):1037-1046.
39. Lachmann H.J., Kone-Paut I., Kuemmerle-Deschner J.B., et al. Use of canakinumab in the cryopyrin-associated periodic syndrome. NEngl J Med 2009, 360(23):2416-2425.
40. Andersson T., Wardell K., Anderson C. Human invivo cutaneous microdialysis: estimation of histamine release in cold urticaria. Acta Derm Venereol 1995, 75(5):343-347.
41. Wasserman S.I., Ginsberg M.H. Release of platelet factor 4 into the blood after cold challenge of patients with cold urticaria. JAllergy Clin Immunol 1984, 74(3 Pt 1):275-279.
42. Hermes B., Prochazka A.K., Haas N., et al. Upregulation of TNF-alpha and IL-3 expression in lesional and uninvolved skin in different types of urticaria. JAllergy Clin Immunol 1999, 103(2 Pt 1):307-314.
43. Gruber B.L., Baeza M.L., Marchese M.J., et al. Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. JInvest Dermatol 1988, 90(2):213-217.
44. Kaplan A.P., Garofalo J., Sigler R., et al. Idiopathic cold urticaria: invitro demonstration of histamine release upon challenge of skin biopsies. NEngl J Med 1981, 305(18):1074-1077.
45. Siebenhaar F., Staubach P., Metz M., et al. Peltier effect-based temperature challenge: an improved method for diagnosing cold urticaria. JAllergy Clin Immunol 2004, 114(5):1224-1225.
46. Mlynek A., Magerl M., Siebenhaar F., et al. Results and relevance of critical temperature threshold testing in patients with acquired cold urticaria. Br J Dermatol 2010, 162(1):198-200.
47. Kozel M.M., Bossuyt P.M., Mekkes J.R., et al. Laboratory tests and identified diagnoses in patients with physical and chronic urticaria and angioedema: a systematic review. JAm Acad Dermatol 2003, 48(3):409-416.
48. Illig L. Positive side-effects of antibiotic and antimicrobial drugs in therapy (author's transl). Infection 1979, 7(Suppl 6):584-588. [in German].
49. Weinstein M.E., Wolff A.H., Bielory L. Efficacy and tolerability of second- and third-generation antihistamines in the treatment of acquired cold urticaria: a meta-analysis. Ann Allergy Asthma Immunol 2010, 104(6):518-522.
50. Siebenhaar F., Degener F., Zuberbier T., et al. High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. JAllergy Clin Immunol 2009, 123(3):672-679.
51. Magerl M., Schmolke J., Siebenhaar F., et al. Acquired cold urticaria symptoms can be safely prevented by ebastine. Allergy 2007, 62(12):1465-1468.
52. Metz M., Scholz E., Ferran M., et al. Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria. Ann Allergy Asthma Immunol 2010, 104(1):86-92.
53. Magerl M., Pisarevskaja D., Staubach P., et al. Critical temperature threshold measurement for cold urticaria: a randomised controlled trial of H1-antihistamine up-dosing. Br J Dermatol 2012, 166:1095-1099.
54. Krause K., Spohr A., Zuberbier T., et al. Up-dosing with bilastine results in improved effectiveness in cold contact urticaria. Allergy 2013, 68(7):921-928.
55. Kring Tannert L., Stahl Skov P., Bjerremann Jensen L., et al. Cold urticaria patients exhibit normal skin levels of functional mast cells and histamine after tolerance induction. Dermatology 2012, 224(2):101-105.
56. Boyce J.A. Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE. JAllergy Clin Immunol 2006, 117(6):1415-1418.
57. Brodska P., Schmid-Grendelmeier P. Treatment of severe cold contact urticaria with omalizumab: case reports. Case Rep Dermatol 2012, 4(3):275-280.
58. Black A.K., Sibbald R.G., Greaves M.W. Cold urticaria treated by induction of tolerance. Lancet 1979, 2(8149):964.
59. von Mackensen Y.A., Sticherling M. Cold urticaria: tolerance induction with cold baths. Br J Dermatol 2007, 157(4):835-836.
60. Bodar E.J., Simon A., de Visser M., et al. Complete remission of severe idiopathic cold urticaria on interleukin-1 receptor antagonist (anakinra). Neth J Med 2009, 67(9):302-305.
61. Gualdi G., Monari P., Rossi M.T., et al. Successful treatment of systemic cold contact urticaria with etanercept in a patient with psoriasis. Br J Dermatol 2012, 166(6):1373-1374.
62. Irwin R.B., Lieberman P., Friedman M.M., et al. Mediator release in local heat urticaria: protection with combined H1 and H2 antagonists. JAllergy Clin Immunol 1985, 76(1):35-39.
63. Fukunaga A., Shimoura S., Fukunaga M., et al. Localized heat urticaria in a patient is associated with a wealing response to heated autologous serum. Br J Dermatol 2002, 147(5):994-997.
64. Bullerkotte U., Wieczorek D., Kapp A., et al. Effective treatment of refractory severe heat urticaria with omalizumab. Allergy 2010, 65(7):931-932.
65. Chong W.S., Khoo S.W. Solar urticaria in Singapore: an uncommon photodermatosis seen in a tertiary dermatology center over a 10-year period. Photodermatol Photoimmunol Photomed 2004, 20(2):101-104.
66. Du-Thanh A., Debu A., Lalheve P., et al. Solar urticaria: a time-extended retrospective series of 61 patients and review of literature. Eur J Dermatol 2013, 23(2):202-207.
67. Stratigos A.J., Antoniou C., Papathanakou E., et al. Spectrum of idiopathic photodermatoses in a Mediterranean country. Int J Dermatol 2003, 42(6):449-454.
68. Ryckaert S., Roelandts R. Solar urticaria. A report of 25 cases and difficulties in phototesting. Arch Dermatol 1998, 134(1):71-74.
69. Monfrecola G., Masturzo E., Riccardo A.M., et al. Solar urticaria: a report on 57 cases. Am J Contact Dermat 2000, 11(2):89-94.
70. Horio T. Solar urticaria-idiopathic?. Photodermatol Photoimmunol Photomed 2003, 19(3):147-154.
71. Harber L.C., Holloway R.M., Wheatley V.R., et al. Immunologic and biophysical studies in solar urticaria. JInvest Dermatol 1963, 41:439-443.
72. Horio T., Minami K. Solar uticaria. Photoallergen in a patient's serum. Arch Dermatol 1977, 113(2):157-160.
73. Horio T. Photoallergic urticaria induced by visible light. Additional cases and further studies. Arch Dermatol 1978, 114(12):1761-1764.
74. Leenutaphong V., Holzle E., Plewig G. Pathogenesis and classification of solar urticaria: a new concept. JAm Acad Dermatol 1989, 21(2 Pt 1):237-240.
75. Guzelbey O., Ardelean E., Magerl M., et al. Successful treatment of solar urticaria with anti-immunoglobulin E therapy. Allergy 2008, 63(11):1563-1565.
76. Duchini G., Baumler W., Bircher A.J., et al. Failure of omalizumab (Xolair(R)) in the treatment of a case of solar urticaria caused by ultraviolet A and visible light. Photodermatol Photoimmunol Photomed 2011, 27(6):336-337.
77. Masuoka E., Fukunaga A., Kishigami K., et al. Successful and long-lasting treatment of solar urticaria with ultraviolet A rush hardening therapy. Br J Dermatol 2012, 167(1):198-201.
78. Wolf R., Herzinger T., Grahovac M., et al. Solar urticaria: long-term rush hardening by inhibition spectrum narrow-band UVB 311 nm. Clin Exp Dermatol 2013, 38(4):446-447.
79. Hughes R., Cusack C., Murphy G.M., et al. Solar urticaria successfully treated with intravenous immunoglobulin. Clin Exp Dermatol 2009, 34(8):e660-e662.
80. Correia I., Silva J., Filipe P., et al. Solar urticaria treated successfully with intravenous high-dose immunoglobulin: a case report. Photodermatol Photoimmunol Photomed 2008, 24(6):330-331.
81. Llamas-Velasco M., Argila D.D., Eguren C., et al. Solar urticaria unresponsive to intravenous immunoglobulins. Photodermatol Photoimmunol Photomed 2011, 27(1):53-54.
82. Haylett A.K., Nie Z., Brownrigg M., et al. Systemic photoprotection in solar urticaria with alpha-melanocyte-stimulating hormone analogue [Nle4-D-Phe7]-alpha-MSH. Br J Dermatol 2011, 164(2):407-414.
83. Keahey T.M., Indrisano J., Lavker R.M., et al. Delayed vibratory angioedema: insights into pathophysiologic mechanisms. JAllergy Clin Immunol 1987, 80(6):831-838.
84. Metzger W.J., Kaplan A.P., Beaven M.A., et al. Hereditary vibratory angioedema: confirmation of histamine release in a type of physical hypersensitivity. JAllergy Clin Immunol 1976, 57(6):605-608.
85. Lawlor F., Black A.K., Breathnach A.S., et al. Vibratory angioedema: lesion induction, clinical features, laboratory and ultrastructural findings and response to therapy. Br J Dermatol 1989, 120(1):93-99.
86. Ting S., Reimann B.E., Rauls D.O., et al. Nonfamilial, vibration-induced angioedema. JAllergy Clin Immunol 1983, 71(6):546-551.
87. Mathelier-Fusade P., Vermeulen C., Leynadier F. Vibratory angioedema. Ann Dermatol Venereol 2001, 128(6-7):750-752. [in French].
88. Pressler A., Grosber M., Halle M., et al. Failure of omalizumab and successful control with ketotifen in a patient with vibratory angio-oedema. Clin Exp Dermatol 2013, 38(2):151-153.
89. Godse K., Farooqui S., Nadkarni N., et al. Prevalence of cholinergic urticaria in Indian adults. Indian Dermatol Online J 2013, 4(1):62-63.
90. Ramam M., Pahwa P. Is cholinergic urticaria a seasonal disorder in some patients?. Indian J Dermatol Venereol Leprol 2012, 78(2):190-191.
91. Petalas K., Kontou-Fili K., Gratziou C. Bronchial hyperresponsiveness in patients with cholinergic urticaria. Ann Allergy Asthma Immunol 2009, 102(5):416-421.
92. Bito T., Sawada Y., Tokura Y. Pathogenesis of cholinergic urticaria in relation to sweating. Allergol Int 2012, 61(4):539-544.
93. Horikawa T., Fukunaga A., Nishigori C. New concepts of hive formation in cholinergic urticaria. Curr Allergy Asthma Rep 2009, 9(4):273-279.
94. Kobayashi H., Aiba S., Yamagishi T., et al. Cholinergic urticaria, a new pathogenic concept: hypohidrosis due to interference with the delivery of sweat to the skin surface. Dermatology 2002, 204(3):173-178.
95. Nakamizo S., Kurosawa M., Sawada Y., et al. Acase of cholinergic urticaria associated with acquired generalized hypohidrosis and reduced acetylcholine receptors: cause and effect?. Clin Exp Dermatol 2011, 36(5):559-560.
96. Sawada Y., Nakamura M., Bito T., et al. Cholinergic urticaria: studies on the muscarinic cholinergic receptor M3 in anhidrotic and hypohidrotic skin. JInvest Dermatol 2010, 130(11):2683-2686.
97. Fantozzi R., Masini E., Blandina P., et al. Release of histamine from rat mast cells by acetylcholine. Nature 1978, 273(5662):473-474.
98. Adachi J., Aoki T., Yamatodani A. Demonstration of sweat allergy in cholinergic urticaria. JDermatol Sci 1994, 7(2):142-149.
99. Takahagi S., Tanaka T., Ishii K., et al. Sweat antigen induces histamine release from basophils of patients with cholinergic urticaria associated with atopic diathesis. Br J Dermatol 2009, 160(2):426-428.
100. Hiragun T., Ishii K., Hiragun M., et al. Fungal protein MGL_1304 in sweat is an allergen for atopic dermatitis patients. JAllergy Clin Immunol 2013, 132:608-615.e4.
101. Nakamizo S., Egawa G., Miyachi Y., et al. Cholinergic urticaria: pathogenesis-based categorization and its treatment options. JEur Acad Dermatol Venereol 2012, 26(1):114-116.
102. Kozaru T., Fukunaga A., Taguchi K., et al. Rapid desensitization with autologous sweat in cholinergic urticaria. Allergol Int 2011, 60(3):277-281.
103. Metz M., Bergmann P., Zuberbier T., et al. Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy. Allergy 2008, 63(2):247-249.
104. Sabroe R.A. Failure of omalizumab in cholinergic urticaria. Clin Exp Dermatol 2010, 35(4):e127-e129.
105. Ujiie H., Shimizu T., Natsuga K., et al. Severe cholinergic urticaria successfully treated with scopolamine butylbromide in addition to antihistamines. Clin Exp Dermatol 2006, 31(4):588-589.
106. Feinberg J.H., Toner C.B. Successful treatment of disabling cholinergic urticaria. Mil Med 2008, 173(2):217-220.
107. Sheraz A., Halpern S. Cholinergic urticaria responding to botulinum toxin injection for axillary hyperhidrosis. Br J Dermatol 2013, 168:1369-1370.